Acute Myeloid Leukemia (AML) is also known as Acute Myelogenous Leukemia. It is a cancer of myeloid cells in the bone marrow. It is characterized by rapid growth of abnormal White Blood Cells (WBCs) that interfere with the production of normal blood cells. AML is the most common acute leukemia affecting adults and its possibility of occurrence increases with age.
Although several factors could be identified responsible for the disease but the specific cause of the disease remains unclear.
AML has various subtypes, therefore diagnosis and treatment will vary accordingly. AML is initially treated with Chemotherapy aimed at inducing a remission; however the patients may have to go for additional chemo or Hematopoietic Stem Cell Transplant. The recent researches into genetics of AML have been developed for better prediction of patient survival duration and effectiveness of type of drugs.
It is recommended that the patients must be mentally, physically, nutritionally and psychologically prepared the treatment.